Chiasson, J.-L
The rapidly increased prescribing of GLP-1 RAs is in line with several studies conducted across all continents [32, 54,55,56,57,58,59,60]
Thats when problems start: fatigue, chronic inflammation, brain fog, or even increased risk of disease
We are aware of no breakthrough or accelerated regulatory designation for a neurodegenerative indication in this class, and the recent Phase 3 failures are likely to make near-term regulatory filings in this space unlikely
Glutathione doesnt require baseline labs to start
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced naturally by specialized L-cells in your intestinal lining, primarily in the ileum and colon